Functional proteomics study reveals SUMOylation of TFII-I is involved in liver cancer cell proliferation

Journal of Proteome Research

Volumn 14, Issue 6, 2015, Pages 2385-2397

  Tu, Jun ^a   Chen, Yalan ^b   Cai, Lili ^a   Xu, Changming ^d   Zhang, Yang ^a   Chen, Yanmei ^a   Zhang, Chen ^a   Zhao, Jian ^a   Cheng, Jinke ^b   Xie, Hongwei ^d   Zhong, Fan ^a   He, Fuchu ^a,c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY   (China)

Author keywords

liver cancer; proteomics; SUMOylation; TFII I; UBA2

Indexed keywords

HISTONE DEACETYLASE 3; MESSENGER RNA; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR II I; TUMOR PROTEIN; UBA2 PROTEIN; UNCLASSIFIED DRUG; GTF2I PROTEIN, HUMAN; SUMO PROTEIN; UBA2 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLONY FORMATION; FEMALE; FUNCTIONAL PROTEOMICS; HEPATOBLASTOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SUMOYLATION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PROTEOMICS;

CELL PROLIFERATION; GENE SILENCING; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROTEOMICS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84930603851     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00062     Document Type: Article

References (60)

1. Hay, R. T. SUMO: a history of modification Mol. Cell 2005, 18 (1) 1-12
2. Boddy, M. N.; Howe, K.; Etkin, L. D.; Solomon, E.; Freemont, P. S. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia Oncogene 1996, 13 (5) 971-982
3. Creton, S.; Jentsch, S. SnapShot: The SUMO system Cell 2010, 143 (5) 848-848 e1
4. Citro, S.; Chiocca, S. Sumo paralogs: redundancy and divergencies Front. Biosci., Scholar Ed. 2013, 5, 544-553
5. Golebiowski, F.; Matic, I.; Tatham, M. H.; Cole, C.; Yin, Y.; Nakamura, A.; Cox, J.; Barton, G. J.; Mann, M.; Hay, R. T. System-wide changes to SUMO modifications in response to heat shock Sci. Signaling 2009, 2 (72) ra24
6. Matafora, V.; DAmato, A.; Mori, S.; Blasi, F.; Bachi, A. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition Mol. Cell. Proteomics 2009, 8 (10) 2243-2255
7. Galisson, F.; Mahrouche, L.; Courcelles, M.; Bonneil, E.; Meloche, S.; Chelbi-Alix, M. K.; Thibault, P. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells Mol. Cell. Proteomics 2011, 10 (2) M110.004796
8. Lamoliatte, F.; Bonneil, E.; Durette, C.; Caron-Lizotte, O.; Wildemann, D.; Zerweck, J.; Wenshuk, H.; Thibault, P. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions Mol. Cell. Proteomics 2013, 12 (9) 2536-2550
9. Blomster, H. A.; Hietakangas, V.; Wu, J.; Kouvonen, P.; Hautaniemi, S.; Sistonen, L. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites Mol. Cell. Proteomics 2009, 8 (6) 1382-1390
10. Schimmel, J.; Eifler, K.; Sigurethsson, J. O.; Cuijpers, S. A.; Hendriks, I. A.; Verlaan-de Vries, M.; Kelstrup, C. D.; Francavilla, C.; Medema, R. H.; Olsen, J. V.; Vertegaal, A. C. Uncovering SUMOylation Dynamics during Cell-Cycle Progression Reveals FoxM1 as a Key Mitotic SUMO Target Protein Mol. Cell 2014, 53 (6) 1053-1066
11. Tammsalu, T.; Matic, I.; Jaffray, E. G.; Ibrahim, A. F.; Tatham, M. H.; Hay, R. T. Proteome-wide identification of SUMO2 modification sites Sci. Signaling 2014, 7 (323) rs2
12. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002 CA-Cancer J. Clin. 2005, 55 (2) 74-108
13. El-Serag, H. B.; Marrero, J. A.; Rudolph, L.; Reddy, K. R. Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 2008, 134 (6) 1752-1763
14. Farazi, P. A.; DePinho, R. A. Hepatocellular carcinoma pathogenesis: from genes to environment Nat. Rev. Cancer 2006, 6 (9) 674-687
15. Villanueva, A.; Newell, P.; Chiang, D. Y.; Friedman, S. L.; Llovet, J. M. Genomics and signaling pathways in hepatocellular carcinoma Semin. Liver Dis. 2007, 27 (1) 55-76
16. Moeini, A.; Cornella, H.; Villanueva, A. Emerging signaling pathways in hepatocellular carcinoma Liver Cancer 2012, 1 (2) 83-93
17. Bettermann, K.; Benesch, M.; Weis, S.; Haybaeck, J. SUMOylation in carcinogenesis Cancer Lett. 2012, 316 (2) 113-125
18. Wang, Q.; Xia, N.; Li, T.; Xu, Y.; Zou, Y.; Zuo, Y.; Fan, Q.; Bawa-Khalfe, T.; Yeh, E. T.; Cheng, J. SUMO-specific protease 1 promotes prostate cancer progression and metastasis Oncogene 2013, 32 (19) 2493-2498
19. Mo, Y. Y.; Yu, Y.; Theodosiou, E.; Ee, P. L.; Beck, W. T. A role for Ubc9 in tumorigenesis Oncogene 2005, 24 (16) 2677-2683
20. Kessler, J. D.; Kahle, K. T.; Sun, T.; Meerbrey, K. L.; Schlabach, M. R.; Schmitt, E. M.; Skinner, S. O.; Xu, Q.; Li, M. Z.; Hartman, Z. C.; Rao, M.; Yu, P.; Dominguez-Vidana, R.; Liang, A. C.; Solimini, N. L.; Bernardi, R. J.; Yu, B.; Hsu, T.; Golding, I.; Luo, J.; Osborne, C. K.; Creighton, C. J.; Hilsenbeck, S. G.; Schiff, R.; Shaw, C. A.; Elledge, S. J.; Westbrook, T. F. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis Science 2012, 335 (6066) 348-353
21. Tomasi, M. L.; Tomasi, I.; Ramani, K.; Pascale, R. M.; Xu, J.; Giordano, P.; Mato, J. M.; Lu, S. C. S -Adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers Hepatology 2012, 56 (3) 982-993
22. Li, J.; Xu, Y.; Long, X. D.; Wang, W.; Jiao, H. K.; Mei, Z.; Yin, Q. Q.; Ma, L. N.; Zhou, A. W.; Wang, L. S.; Yao, M.; Xia, Q.; Chen, G. Q. Cbx4 governs HIF-1alpha to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity Cancer Cell 2014, 25 (1) 118-131
23. Shen, H. J.; Zhu, H. Y.; Yang, C.; Ji, F. SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of beta-catenin Asian Pacific Journal of Cancer Prevention 2012, 13 (8) 3583-3587
24. Guo, W. H.; Yuan, L. H.; Xiao, Z. H.; Liu, D.; Zhang, J. X. Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma J. Cancer Res. Clin. Oncol. 2011, 137 (3) 533-541
25. Cheng, J.; Kang, X.; Zhang, S.; Yeh, E. T. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia Cell 2007, 131 (3) 584-595
26. Ohshima, T.; Koga, H.; Shimotohno, K. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification J. Biol. Chem. 2004, 279 (28) 29551-29557
27. Yang, S. T.; Yen, C. J.; Lai, C. H.; Lin, Y. J.; Chang, K. C.; Lee, J. C.; Liu, Y. W.; Chang-Liao, P. Y.; Hsu, L. S.; Chang, W. C.; Hung, W. C.; Tang, T. K.; Liu, Y. W.; Hung, L. Y. SUMOylated CPAP is required for IKK-mediated NF-kappaB activation and enhances HBx-induced NF-kappaB signaling in HCC J. Hepatol. 2013, 58 (6) 1157-1164
28. Zhao, J.; Yu, H.; Lin, L.; Tu, J.; Cai, L.; Chen, Y.; Zhong, F.; Lin, C.; He, F.; Yang, P. Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF) J. Proteomics 2011, 75 (2) 588-602
29. Chinese Human Liver Proteome Profiling Consortium First insight into the human liver proteome from PROTEOME(SKY)-LIVER(Hu) 1.0, a publicly available database J. Proteome Res. 2010, 9 (1) 79-94
30. Wu, S.; Li, N.; Ma, J.; Shen, H.; Jiang, D.; Chang, C.; Zhang, C.; Li, L.; Zhang, H.; Jiang, J.; Xu, Z.; Ping, L.; Chen, T.; Zhang, W.; Zhang, T.; Xing, X.; Yi, T.; Li, Y.; Fan, F.; Li, X.; Zhong, F.; Wang, Q.; Zhang, Y.; Wen, B.; Yan, G.; Lin, L.; Yao, J.; Lin, Z.; Wu, F.; Xie, L.; Yu, H.; Liu, M.; Lu, H.; Mu, H.; Li, D.; Zhu, W.; Zhen, B.; Qian, X.; Qin, J.; Liu, S.; Yang, P.; Zhu, Y.; Xu, P.; He, F. First proteomic exploration of protein-encoding genes on chromosome 1 in human liver, stomach, and colon J. Proteome Res. 2013, 12 (1) 67-80
31. Kang, X.; Qi, Y.; Zuo, Y.; Wang, Q.; Zou, Y.; Schwartz, R. J.; Cheng, J.; Yeh, E. T. SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development Mol. Cell 2010, 38 (2) 191-201
32. Liu, B.; Wang, T.; Mei, W.; Li, D.; Cai, R.; Zuo, Y.; Cheng, J. Small ubiquitin-like modifier (SUMO) protein-specific protease 1 de-SUMOylates Sharp-1 protein and controls adipocyte differentiation J. Biol. Chem. 2014, 289 (32) 22358-22364
33. Vertegaal, A. C.; Ogg, S. C.; Jaffray, E.; Rodriguez, M. S.; Hay, R. T.; Andersen, J. S.; Mann, M.; Lamond, A. I. A proteomic study of SUMO-2 target proteins J. Biol. Chem. 2004, 279 (32) 33791-33798
34. Rosas-Acosta, G.; Russell, W. K.; Deyrieux, A.; Russell, D. H.; Wilson, V. G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers Mol. Cell. Proteomics 2005, 4 (1) 56-72
35. Manza, L. L.; Codreanu, S. G.; Stamer, S. L.; Smith, D. L.; Wells, K. S.; Roberts, R. L.; Liebler, D. C. Global shifts in protein sumoylation in response to electrophile and oxidative stress Chem. Res. Toxicol. 2004, 17 (12) 1706-1715
36. Guo, D.; Han, J.; Adam, B. L.; Colburn, N. H.; Wang, M. H.; Dong, Z.; Eizirik, D. L.; She, J. X.; Wang, C. Y. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress Biochem. Biophys. Res. Commun. 2005, 337 (4) 1308-1318
37. Vertegaal, A. C.; Andersen, J. S.; Ogg, S. C.; Hay, R. T.; Mann, M.; Lamond, A. I. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics Mol. Cell. Proteomics 2006, 5 (12) 2298-2310
38. Westman, B. J.; Verheggen, C.; Hutten, S.; Lam, Y. W.; Bertrand, E.; Lamond, A. I. A proteomic screen for nucleolar SUMO targets shows SUMOylation modulates the function of Nop5/Nop58 Mol. Cell 2010, 39 (4) 618-631
39. Vigodner, M.; Shrivastava, V.; Gutstein, L. E.; Schneider, J.; Nieves, E.; Goldstein, M.; Feliciano, M.; Callaway, M. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa Hum. Reprod. 2013, 28 (1) 210-223
40. Zheng, Q.; Ye, J.; Cao, J. Translational regulator eIF2alpha in tumor Tumor Biol. 2014, 35 (7) 6255-6264
41. Grzybowska, E. A. Human intronless genes: functional groups, associated diseases, evolution, and mRNA processing in absence of splicing Biochem. Biophys. Res. Commun. 2012, 424 (1) 1-6
42. Xue, Y.; Zhou, F.; Fu, C.; Xu, Y.; Yao, X. SUMOsp: a web server for sumoylation site prediction Nucleic Acids Res. 2006, 34 (suppl 2) W254-257
43. Lachenmayer, A.; Toffanin, S.; Cabellos, L.; Alsinet, C.; Hoshida, Y.; Villanueva, A.; Minguez, B.; Tsai, H. W.; Ward, S. C.; Thung, S.; Friedman, S. L.; Llovet, J. M. Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib J. Hepatol. 2012, 56 (6) 1343-1350
44. Kogure, T.; Kinghorn, A. D.; Yan, I.; Bolon, B.; Lucas, D. M.; Grever, M. R.; Patel, T. Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer PLoS One 2013, 8 (9) e76136
45. Heringlake, S.; Hofdmann, M.; Fiebeler, A.; Manns, M. P.; Schmiegel, W.; Tannapfel, A. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours J. Hepatol. 2010, 52 (2) 220-227
46. Zeindl-Eberhart, E.; Haraida, S.; Liebmann, S.; Jungblut, P. R.; Lamer, S.; Mayer, D.; Jager, G.; Chung, S.; Rabes, H. M. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas Hepatology (Hoboken, NJ, U.S.) 2004, 39 (2) 540-549
47. Roy, A. L.; Meisterernst, M.; Pognonec, P.; Roeder, R. G. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF Nature 1991, 354 (6350) 245-248
48. Desgranges, Z. P.; Ahn, J.; Lazebnik, M. B.; Ashworth, T.; Lee, C.; Pestell, R. C.; Rosenberg, N.; Prives, C.; Roy, A. L. Inhibition of TFII-I-dependent cell cycle regulation by p53 Mol. Cell. Biol. 2005, 25 (24) 10940-10952
49. Mammoto, A.; Connor, K. M.; Mammoto, T.; Yung, C. W.; Huh, D.; Aderman, C. M.; Mostoslavsky, G.; Smith, L. E.; Ingber, D. E. A mechanosensitive transcriptional mechanism that controls angiogenesis Nature 2009, 457 (7233) 1103-1108
50. Wen, Y. D.; Cress, W. D.; Roy, A. L.; Seto, E. Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I J. Biol. Chem. 2003, 278 (3) 1841-1847
51. Matic, I.; Schimmel, J.; Hendriks, I. A.; van Santen, M. A.; van de Rijke, F.; van Dam, H.; Gnad, F.; Mann, M.; Vertegaal, A. C. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif Mol. Cell 2010, 39 (4) 641-652
52. Hendriks, I. A.; DSouza, R. C.; Yang, B.; Verlaan-de Vries, M.; Mann, M.; Vertegaal, A. C. Uncovering global SUMOylation signaling networks in a site-specific manner Nat. Struct. Mol. Biol. 2014, 21 (10) 927-936
53. Xu, X.; Vatsyayan, J.; Gao, C.; Bakkenist, C. J.; Hu, J. Sumoylation of eIF4E activates mRNA translation EMBO Rep. 2010, 11 (4) 299-304
54. Dai, R.; Yan, D.; Li, J.; Chen, S.; Liu, Y.; Chen, R.; Duan, C.; Wei, M.; Li, H.; He, T. Activation of PKR/eIF2alpha signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells J. Cell. Biochem. 2012, 113 (5) 1800-1808
55. Wang, X. L.; Cai, H. P.; Ge, J. H.; Su, X. F. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma World J. Gastroenterol. 2012, 18 (20) 2540-2544
56. Tang, D. J.; Dong, S. S.; Ma, N. F.; Xie, D.; Chen, L.; Fu, L.; Lau, S. H.; Li, Y.; Li, Y.; Guan, X. Y. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma Hepatology (Hoboken, NJ, U.S.) 2010, 51 (4) 1255-1263
57. Leclercq, T. M.; Moretti, P. A.; Pitson, S. M. Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis Oncogene 2011, 30 (3) 372-378
58. Zhao, Y.; Kwon, S. W.; Anselmo, A.; Kaur, K.; White, M. A. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins J. Biol. Chem. 2004, 279 (20) 20999-21002
59. Tussie-Luna, M. I.; Michel, B.; Hakre, S.; Roy, A. L. The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta /Siz2 is a transcriptional cofactor for TFII-I J. Biol. Chem. 2002, 277 (45) 43185-43193
60. Nait Achour, T.; Sentis, S.; Teyssier, C.; Philippat, A.; Lucas, A.; Corbo, L.; Cavailles, V.; Jalaguier, S. Transcriptional repression of estrogen receptor alpha signaling by SENP2 in breast cancer cells Mol. Endocrinol. 2014, 28 (2) 183-196